Sanofi (Sanofi) Days Inventory

: 436.92 (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Sanofi's Average Total Inventories for the six months ended in Jun. 2023 was $16,463 Mil. Sanofi's Cost of Goods Sold for the six months ended in Jun. 2023 was $6,876 Mil. Hence, Sanofi's Days Inventory for the six months ended in Jun. 2023 was 436.92.

The historical rank and industry rank for Sanofi's Days Inventory or its related term are showing as below:

SNY' s Days Inventory Range Over the Past 10 Years
Min: 215.52 Med: 232.96 Max: 344.04
Current: 344.04

During the past 13 years, Sanofi's highest Days Inventory was 344.04. The lowest was 215.52. And the median was 232.96.

SNY's Days Inventory is ranked worse than
87.59% of 975 companies
in the Drug Manufacturers industry
Industry Median: 157.96 vs SNY: 344.04

Sanofi's Days Inventory increased from Jun. 2022 (278.09) to Jun. 2023 (436.92). It might indicate that Sanofi's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sanofi's Inventory Turnover for the six months ended in Jun. 2023 was 0.42.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sanofi's Inventory-to-Revenue for the six months ended in Jun. 2023 was 0.71.

Sanofi Days Inventory Historical Data

The historical data trend for Sanofi's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

238.42

240.39

269.51

243.28

235.49

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory																252.69	278.09	220.81	436.92	360.37

Competitive Comparison

For the Drug Manufacturers - General subindustry, Sanofi's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi Days Inventory Distribution

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Days Inventory distribution charts can be found below:

* The bar in red indicates where Sanofi's Days Inventory falls into.

Sanofi Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sanofi's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (9491.525	+	10540.894)	/	2 )	/	15524.536	*	365
=	10016.2095					/	15524.536	*	365
=	235.49

Sanofi's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

	Days Inventory (Q: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2022 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (9491.525	+	23434.453)	/	2 )	/	6876.49	*	365 / 2
=	16462.989					/	6876.49	*	365 / 2
=	436.92

Sanofi (NAS:SNY) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sanofi's Inventory Turnover for the six months ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	6876.49	/	16462.989
	=	0.42

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sanofi's Inventory to Revenue for the six months ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	16462.989	/	23342.362
	=	0.71

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Sanofi Days Inventory Related Terms

Thank you for viewing the detailed overview of Sanofi's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.